NCBIO, the North Carolina Biosciences Organization
NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.
Member Benefits
A variety of discount programs are available to members.
Partners and Resources
NCBIO works with national organizations and connects with many North Carolina life science resources.
BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy
On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the…
Read MoreBiotech joins efforts to aid in humanitarian relief in Ukraine
The biotech and life sciences industry is coming together to donate a range of critical medical supplies, equipment, and medications…
Read MoreCMS decision not to cover Alzheimer’s treatment a bad one
NCBIO stands in solidarity with patient advocates and industry leaders in opposing the Centers for Medicare and Medicaid Services’ draft…
Read MoreWho pays to create new medicines?
Does government spending on drug development justify government price controls on medicines? Not when the private sector spends $102 billion on clinical R&D and the NIH spends less than $3 billion.
Read MoreLead gifts from Alexandria Real Estate, Biogen, Hatteras push Taylor scholarship fund past $200,000
The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners.
Read MoreNCBIO forum explores moving technology through funding phases
A high quality board of directors and valuable outside partnerships are two advantages that biotech startups would do well to cultivate, according to the expert panelists assembled for the NCBIO Emerging Company and Technology Forum held Wednesday, March 16, at the NC Biotechnology Center.
Read MoreNCBIO Roadmap to Diversity event offers guidance for member DEI initiatives
NCBIO members gathered at the NC Biotechnology Center Wednesday, March 9, to seek inspiration and guidance in pursuing their companies’ diversity, equity and inclusion goals. Some key takeaways from the discussions included the need to weave DEI into everything the company does; it can’t stand alone.
Read MoreBMF presenters share lessons learned commissioning facilities during pandemic
At the NCBIO Biomanufacturers Forum held online Feb. 23, representatives from FUJIFILM Diosynth Biotechnologies, Lilly and Project Farma shared what they had learned about commissioning new facilities and equipment during the during the COVID-19 pandemic.
Read MoreSustaining Members





Supporting Members




